Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Indo Us Bio-Tech Ltd - 541304 - SUBMISSION OF NOTICE OF EXTRA ORDINARY GENERAL MEETING(EGM) TO BE HELD ON WEDNESDAY, 25.05.2022

 Pursuant to Regulation 30(6) and Part A of Schedule III of Securities Exchange board of India (Listing Obligations and Disclosures requirements) Regulations, 2015, we hereby enclose herewith Notice along with e-voting instructions of Extra Ordinary General Meeting (EGM) of the company which is scheduled to be held on Wednesday, 25th May, 2022 at 11.00 a.m. through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM'). You are requested to take the same on your record. Thanking You.
03-05-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, 2Nd Day Of May, 2022

 This is to inform you that, the Board of Directors at their Meeting held on today i.e., 2nd Day of May, 2022 at 4:00 P.M. at the registered office of the Company, had considered and approved the following: 1. Calling of Extra Ordinary General Meeting (EGM) on 25.05.2022 at 11.00 am to approve the agenda(s) through VC/ OAVM to comply regulation 170(2) of SEBI ICDR for according fresh approval to allotment of 18,85,112 equity shares on Preferential allotment basis by the members, for which approval of Board was given in their meeting convened on 21.03.2022, but was time barred and thus fresh approval of same was mandated by Exchange. 2. Approve the draft notice of Extra-Ordinary General Meeting (EGM) held on 25.05.2022. 3. Appointment of M/s A. Santoki & Associates as a Scrutinizer of the Extra Ordinary General Meeting (EGM). 4. The e-voting period shall commence from 22/05/2022, 9:00 AM to 24/05/2022, 5:00 PM. 5. Any other business with the permission of the Board Chair.
02-05-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Board Meeting Intimation for Calling The Extra Ordinary General Meeting And Any Other Matter With The Permission Of The Chair To Comply Regulation 29 SEBI LODR.

 Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2022 ,inter alia, to consider and approve and to Call the Extra Ordinary General Meeting and Any other Matter with the permission of the Chair to comply Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Regulations").
26-04-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Submission Of Certificate Under Regulation 40(9) And 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended On 31St March, 2022.

 We are submitting herewith the certificate under Regulation 40(9) & 40(10) of the SEBI (LODR) Regulation 2015 obtained from Practicing Company Secretary for the Year ended on 31st March, 2022. Kindly take the same on your record. Thanking you.
19-04-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Compliance Certificate For The Period Ended March, 2022

 We hereby certify that all activities in relation to both physical and electronic share transfer facilities are maintained by our Registrar and Share Transfer Agent i.e., Bigshare Services Private Limited (SEBI Reg. No. INR000001385) having its Office at A/802, Samundra Complex, Near Klassic Gold, Girish cold drink, C.G. Road, Ahmedabad-380009, Gujarat. Further, we confirm that Bigshare Services Private Limited is registered with Securities and Exchange Board of India to act as Registrar and Transfer Agents. Further, pursuant to Regulation 7(3) of the LODR Regulations, we are submitting the compliance certificate for the Half Year/ financial year ended on 31st March, 2022 i.e., for the period from October 1, 2021 to March 31, 2022. We request you to take this certificate on record.
08-04-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We herewith enclose a Certificate dated 4th April, 2022 under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter/year ended 31st March, 2022 received from M/s. Bigshare Services Private Limited, Registrar and Share Transfer Agent of our company. Thanking you Yours Faithfully
08-04-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Statement Of Investor Complaints For The Quarter Ended March 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dimpy JoshiDesignation :- Company Secretary and Compliance Officer
08-04-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Non-Applicability Of Regulation 24A Of SEBI (Listing Obligations And Disclosure Requirement) Regulation, 2015 Read With Regulation 15 Of SEBI (Listing Obligations And Disclosure Requirement) Regulations, 2015.

 Dear Sir, The Securities and Exchange Board of India has amended SEBI (Listing obligations and Disclosure Requirements) Regulation, 2015 and included 24A Regulation as under: 24A: Secretarial Audit, Every Listed Company and its material unlisted subsidiaries incorporated in India shall undertake secretarial audit and shall annex with its annual report, a secretarial audit report, given by a Company Secretary in practice. Further, as per the provisions of Regulation 15 of SEBI (Listing obligations and Disclosure Requirements) Regulation, 2015 the compliance with the corporate governance provisions as specified in regulation 24A shall not apply, in respect of: a) the listed entity having paid up equity share capital not exceeding rupees ten crore and net worth not exceeding rupees twenty-five crore, as on the last day of the previous financial year. b) the listed entity which has listed its specified securities on the SME Exchange. This is for your information and records.
08-04-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Confirmation Regarding Not Falling Under Large Corporate Criteria With Reference To SEBI Circular No SEB/HO/DDHS/CIR/P/2018/144 Dated November 26, 2018 And BSE Circular Dated April 11, 2019.

 Pursuant to SEBI Circular No: SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 with regard to fund raising by issuance of debt securities by large entities and BSE Circular No. LIST/COMP/05/2019-20 dated April 11, 2019, we would like to confirm that the Company does not fulfil the criteria specified in Para 2.2 of the above-mentioned SEBI Circular and hence does not fall in the category of 'Large Corporate' and cannot be considered as a Large Corporate defined under the said circular. Kindly take the same on your record. Thanking You,
08-04-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Submission Of Annual Disclosure Under Regulation 30(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 For The Year Ended 31St March, 2022

 enclosed herewith a copy of Annual Disclosure under Regulation 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, for the year ended 31st March, 2022 received from Mr. Jagdishkumar Devjibhai Ajudiya Promoter of the Company on behalf of himself and other Members of Promoter & Promoter Group. Kindly take the same on your record. Thanking You
06-04-2022
Next Page
Close

Let's Open Free Demat Account